February 24, 2021
Minnesota Medical Technologies Corporation (Minnesota Medical), a medical device manufacturing company based in Stewartville, MN, U.S, and Wellspect Healthcare (Wellspect), headquartered in Mölndal, Sweden and a part of U.S. based Dentsply Sirona, have entered into an agreement for the distribution of Minnesota Medical’s fecal incontinence insert throughout Europe.
David A. Jonas, Minnesota Medical’s CEO commented: “We are pleased to announce this exciting, strategic partnership with Wellspect.
This collaboration puts our innovative technology in the hands of one of the world’s leading providers of continence care solutions. Wellspect has the infrastructure and relationships to immediately begin marketing and distributing this life-changing product throughout Europe. Without question, this will accelerate our growth curve.”
The completion of this strategic distribution agreement provides Wellspect the exclusive rights to distribute Minnesota Medical’s innovative fecal incontinence insert device in markets across Europe. The product, which has been approved for sale in Europe, will be marketed under Wellspect’s Navina™ brand.
“Supporting our customers and users is at the heart of everything we do, we are constantly searching for collaborations with companies that have unique and innovative products in our core areas. It is therefore with pleasure that we can now launch the Navina Incontinence Insert, which is the result of our strategic collaboration with Minnesota Medical Technologies,” says Svenn Poulsen, Group Vice President, Wellspect Healthcare.